AusPAR: Lixisenatide

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

14 October 2013
AusPAR Details
AusPAR
AusPAR: Lixisenatide (pdf, 1 MB)
AusPAR: Lixisenatide (docx, 2 MB)
Attachment: Product Information: Lixisenatide (pdf, 332 KB)
Attachment: Product Information: Lixisenatide (docx, 170 KB)
Attachment: Extract from Clinical Evaluation Report: Lixisenatide (pdf, 2 MB)
Attachment: Extract from Clinical Evaluation Report: Lixisenatide (docx, 2 MB)
Active Ingredient
Lixisenatide
Product Name
Lyxumia / Lyxumia Treatment initiation pack / Lixisenatide Sanofi / Lixisenatide Sanofi Treatment initiation pack / Lixisenatide Winthrop / Lixisenatide Winthrop Treatment initiation packLyxumia / Lyxumia Treatment initiation pack / Lixisenatide Sanofi / Lixisenatide Sanofi Treatment initiation...
Sponsor
Sanofi-Aventis Australia Pty Ltd
Submission Number
PM-2011-03163-3-5
Submission Type
New chemical entity
Decision
Approved
AusPAR Date
20 August 2013
Publication Date

14 October 2013
Tags: 
AusPARs
URL: 
https://www.tga.gov.au/node/1052